Full Breakdown
FDA Withdraws Proposed Rule on Tanning Bed Use for Minors
3/19/2026, 11:47:30 AM
Overview of the FDA's Decision
On Tuesday, the Food and Drug Administration (FDA) withdrew a proposed rule that aimed to prohibit all Americans under the age of 18 from using tanning beds. This proposal, first introduced in 2015, sought to address health concerns associated with ultraviolet (UV) radiation exposure, which is linked to skin cancer. Currently, 22 states and Washington, D.C. have enacted bans on indoor tanning for minors, while others allow use with parental consent.
Health Risks Associated with Tanning Beds
Tanning beds emit UV radiation at levels up to 15 times greater than natural sunlight, significantly increasing the risk of skin cancer. According to the American Academy of Dermatology, using tanning beds before age 20 can elevate the risk of developing melanoma by nearly 50%. A 2025 study indicated that melanoma rates among frequent tanning bed users were more than double those who did not use them. Despite these risks, a survey found that nearly 60% of adult Gen Zers held misconceptions about tanning, believing, for instance, that a base tan could prevent sunburn.
Official Statements and Responses
The FDA's withdrawal was attributed to "scientific and technical concerns" raised in over 8,100 comments received from various stakeholders, including medical associations and cancer advocacy groups. An FDA spokesperson emphasized that the withdrawal does not negate the health risks associated with UV exposure, urging users to consult with healthcare professionals before using tanning products. Dr. Susan Taylor, president of the American Academy of Dermatology, expressed disappointment, stating that restricting access to tanning beds is crucial for preventing skin cancer.
Criticism of the FDA's Withdrawal
Critics argue that the FDA's decision undermines public health efforts. Dr. Kavita Mariwalla, president of the American Society for Dermatologic Surgery, lamented that the withdrawal suggests tanning beds are safe, despite evidence of their cancer-causing potential. Dr. Deborah Sarnoff, president of The Skin Cancer Foundation, highlighted the dangers of exposing young people to UV radiation, noting that minors often underestimate the risks involved.
Conflicting Reports and Gaps
While the FDA's withdrawal has been met with criticism, it has also raised concerns about the implications for state-level regulations. Some experts believe that the absence of federal guidelines may hinder legislative efforts at both state and national levels. The FDA's spokesperson indicated that the agency may revisit the issue in the future, leaving open the possibility for renewed rulemaking.
What's Next?
The FDA's decision has sparked discussions about the need for stronger regulations regarding tanning bed use among minors. Advocacy groups continue to call for the reintroduction of the proposed rule, emphasizing the importance of protecting young people from the risks associated with indoor tanning. As the conversation evolves, stakeholders are closely monitoring the FDA's future actions on this critical public health issue.
